Quality of life measures: use and abuse

DL Scott, T Garrood - Best Practice & Research Clinical Rheumatology, 2000 - Elsevier
Health status and quality of life measures are widely used in the clinical assessment of
rheumatoid and other forms of arthritis. A range of measures is available, mainly as self-…

Therapeutic benefit of blocking interleukin‐6 activity with an anti–interleukin‐6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double‐blind …

EHS Choy, DA Isenberg, T Garrood… - Arthritis & …, 2002 - Wiley Online Library
Objective To investigate the safety and efficacy of MRA, a recombinant human anti–interleukin‐6
(anti–IL‐6) receptor monoclonal antibody of the IgG1 subclass that inhibits the function …

The Clinical Impact of Electronic Patient‐Reported Outcome Measures in the Remote Monitoring of Inflammatory Arthritis: A Systematic Review and Meta‐analysis

…, S Norton, JB Galloway, T Garrood - Arthritis & …, 2023 - Wiley Online Library
Objective The inflammatory arthritides (IAs) make up a significant proportion of conditions
followed up in rheumatology clinics. These patients require regular monitoring, but this is …

Molecular mechanisms of cell recruitment to inflammatory sites: general and tissue-specific pathways

T Garrood, L Lee, C Pitzalis - Rheumatology, 2006 - academic.oup.com
The observation that circulating leucocytes adhere to and migrate across the vascular
endothelium was first made 70yr ago; this was noted to occur without breach of the endothelial …

[PDF][PDF] Interleukin‐17+ CD8+ T cells are enriched in the joints of patients with psoriatic arthritis and correlate with disease activity and joint damage progression

…, GJ Walter, M Rajasekhar, T Garrood… - Arthritis & …, 2014 - Wiley Online Library
… IL-17 T cells and other cytokineexpressing T cells (CD4 versus CD4 T cells) in the peripheral
blood (PB) and synovial fluid (SF) of patients with PsA. Our findings show that IL-17CD4 T

[PDF][PDF] Clinical utility of random anti–tumor necrosis factor drug–level testing and measurement of antidrug antibodies on the long‐term treatment response in …

…, V Saravanan, A Cope, T Garrood… - Arthritis & …, 2015 - Wiley Online Library
Objective To investigate whether antidrug antibodies and/or drug non‐trough levels predict
the long‐term treatment response in a large cohort of patients with rheumatoid arthritis (RA) …

Hydroxychloroquine effectiveness in reducing symptoms of hand osteoarthritis: a randomized trial

…, T Garrood, M Green, A Menon, T Sheeran… - Annals of internal …, 2018 - acpjournals.org
… In RA, therapeutic activity has been linked to modulation of antigen-processing activity,
including inhibition of T-cell activation and cytokine release (46, 47); increasing evidence of …

Flares in rheumatoid arthritis patients with low disease activity: predictability and association with worse clinical outcomes

K Bechman, L Tweehuysen, T Garrood… - The Journal of …, 2018 - jrheum.org
Objective. To investigate predictors of flare in rheumatoid arthritis (RA) patients with low disease
activity (LDA) and to evaluate the effect of flare on 12-month clinical outcomes. Methods. …

Delivering outpatient virtual clinics during the COVID-19 pandemic: early evaluation of clinicians' experiences

…, M Cashman, B Malhotra, T Garrood - BMJ open …, 2022 - bmjopenquality.bmj.com
… All clinicians described rapid redesign of their respective services: ‘We had to do it due to
a crisis, we hadn’t really planned and prepared to do it properly’ (physiotherapist) and ‘All the …

[HTML][HTML] Pain reduction with oral methotrexate in knee osteoarthritis, a pragmatic phase iii trial of treatment effectiveness (PROMOTE): study protocol for a randomized …

…, F Birrell, K Cocks, M Doherty, CJ Edwards, T Garrood… - Trials, 2015 - Springer
… Gadolinium-enhanced 1.5/3.0 T MRI of the signal knee will be performed at baseline and
six months according to the protocol outlined in Table 3. All images will be quality controlled by …